SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-22-003503
Filing Date
2022-05-10
Accepted
2022-05-10 14:15:10
Documents
1
Period of Report
2022-05-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4596
  Complete submission text file 0001171843-22-003503.txt   6011
Mailing Address C/O RELYPSA, INC. 700 SAGINAW DR. REDWOOD CITY CA 94063
Business Address
Schuetz Thomas J. (Reporting) CIK: 0001591464 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39696 | Film No.: 22908855

Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences